Shannon Westin

The University of Texas MD Anderson Cancer Center Support Grant (CCSG)

National Cancer Institute · P30

Project lead · $1.5M · University of Tx Md Anderson Can Ctr

The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer

National Cancer Institute · P50

Project lead · $341.5K · University of Tx Md Anderson Can Ctr

Paul Calabresi Clinical Oncology Award

National Cancer Institute · K12

PI · $2.5M · University of Tx Md Anderson Can Ctr

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Principal investigator · Recruiting · Phase 1

M.D. Anderson Cancer Center

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Principal investigator · Recruiting · Phase 1

M.D. Anderson Cancer Center

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Principal investigator · Active not recruiting · Phase 2

National Cancer Institute (NCI)

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Principal investigator · Active not recruiting · Early phase 1

M.D. Anderson Cancer Center